The Vice Presidents at Foghorn Therapeutics are responsible for leading their respective departments and driving the company's strategic initiatives. They oversee crucial areas such as investor relations, drug discovery, chemistry, biology, corporate affairs, and information technology. Together, they ensure cohesive execution of the company's mission to develop innovative medicines targeting the chromatin regulatory system by leveraging the Gene Traffic Control platform.
Ben Strain
VP, Investor Relations & Corpo...
Chong-Hui Gu
Head Of CMC And QA
Dan Dinu
Vice President, Head Of IT
Danette L. Daniels
Vice President, Protein Degrad...
Gromek Smolen
Vp, Head Of Biology
Karin Hellsvik
Vice President, Corporate Affa...
Kevin Wilson
VP, Chemistry
Marina Nelen
VP, Drug Discovery
Murphy Hentemann
VP, Program Leadership
Saurabh Sewak
Head Of Business Development A...
View all